Sign Out
Lamotrigine (Lanistor) tablets are indicated for the following: Epilepsy: Adults and adolescents aged 13 years and above: Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures.
Seizures associated with Lennox-Gastaut syndrome. Lanistor is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.
Children and adolescents aged 2 to 12 years: Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.
Monotherapy of typical absence seizures.
Bipolar disorder: Adults aged 18 years and above: Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.
Lanistor is not indicated for the acute treatment of manic or depressive episodes.
